Feltl And Company Recent News
UPDATE: Feltl and Company Reiterates Buy Rating, Lowers PT on Rochester Medical Corporation
UPDATE: Feltl and Company Upgrades ValueVision Media to Buy on Favorable Outlook
UPDATE: Feltl and Company Downgrades Metropolitan Health Networks to Hold
UPDATE: Feltl and Company Downgrades Cirrus Logic to Hold on Potential Headwinds
UPDATE: Feltl and Company Downgrades MIPS Technologies to Hold
UPDATE: Feltl and Company Raises PT to $121 on DaVita Post Solid Q3
UPDATE: Feltl and Company Upgrades Arctic Cat to Strong Buy on Positive Outlook
UPDATE: Feltl and Company Downgrades Synaptics to Sell on Risks
UPDATE: Feltl and Company Downgrades Cabela's to Hold, Raises PT
UPDATE: Feltl and Company Initiates Black Diamond at Buy on Growth Outlook
UPDATE: Feltl and Company Upgrades Cirrus Logic to Strong Buy, Reiterates $54 PT
UPDATE: Feltl and Company Reiterates Buy Rating, Raises PT on Vascular Solutions
UPDATE: Feltl and Company Initiates Limoneira at Strong Buy on Transformation Outlook
UPDATE: Feltl and Company Upgrades Synaptics to Hold; Near Term Expectations Reset
UPDATE: Feltl and Company Reiterates NxStage Medical at Hold; Reduces 2012 Revenue Estimates
UPDATE: Feltl and Company Raises PT to $12.75 on Novadaq Technologies Post Analyst Day
UPDATE: Feltl and Company Initiates Ellie Mae at Buy on Growth Outlook
UPDATE: Feltl and Company Downgrades Titan Machinery to Buy
UPDATE: Feltl and Company Initiates Synaptics at Sell
UPDATE: Feltl and Company Initiates Atmel Corporation at Hold
Feltl and Company Reiterates Strong Buy Rating, $40 PT on Rentech Nitrogen Partners
UPDATE: Feltl and Company Reiterates Strong Buy Rating, Raises PT on Rentech Nitrogen Partners
UPDATE: Feltl and Company Reiterates Hold Rating, Lowers PT on Amtech Systems